Moody National Bank Trust Division’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$860K Hold
58,975
0.07% 261
2026
Q1
$438K Sell
58,975
-31,791
-35% -$335K 0.04% 359
2025
Q4
$1.07M Buy
90,766
+290
+0.3% +$3.13K 0.1% 203
2025
Q3
$698K Buy
90,476
+1,227
+1% +$8.59K 0.06% 307
2025
Q2
$652K Buy
89,249
+3,902
+5% +$31.5K 0.06% 305
2025
Q1
$810K Buy
85,347
+12,121
+17% +$151K 0.08% 269
2024
Q4
$1.21M Buy
73,226
+12,314
+20% +$191K 0.13% 186
2024
Q3
$898K Buy
60,912
+26,522
+77% +$415K 0.1% 247
2024
Q2
$477K Hold
34,390
0.04% 318
2024
Q1
$541K Hold
34,390
0.04% 315
2023
Q4
$556K Buy
34,390
+6,281
+22% +$103K 0.04% 313
2023
Q3
$346K Hold
28,109
0.02% 479
2023
Q2
$452K Buy
28,109
+5,260
+23% +$86.7K 0.03% 402
2023
Q1
$398K Buy
22,849
+5,817
+34% +$82.9K 0.03% 434
2022
Q4
$157K Buy
17,032
+1,751
+11% +$16.3K 0.01% 586
2022
Q3
$132K Buy
+15,281
New +$152K 0.01% 571
2019
Q2
Sell
-338
Closed -$7K 752
2019
Q1
$7K Buy
+338
New +$5.87K ﹤0.01% 725

Other funds holding NEO

Moody National Bank Trust Division's NEO Position: Q2 2026 in Review

Moody National Bank Trust Division held its NeoGenomics (NEO) position steady in Q2 2026 at 58,975 shares worth $860K. The position accounts for 0.07% of the portfolio, ranked #261.

Moody National Bank Trust Division first reported a position in NEO in Q1 2019 and has held it in 17 quarters since. The position peaked at $1.21M in Q4 2024. 57 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Moody National Bank Trust Division held 58,975 shares of NeoGenomics worth $860K as of Q2 2026.
  • Moody National Bank Trust Division left its NeoGenomics share count unchanged in Q2 2026.
  • NeoGenomics made up 0.07% of Moody National Bank Trust Division's portfolio in Q2 2026, its #261 holding.
  • Moody National Bank Trust Division first reported a position in NeoGenomics in Q1 2019 and has held it in 17 quarters since.
  • Moody National Bank Trust Division's NeoGenomics position peaked at $1.21M in Q4 2024.
  • 57 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Moody National Bank Trust Division's 13F filing for Q2 2026, filed 7 Jul 2026.